The present study suggests a novel key role of hepatic HNF4α in preventing not only the fatty liver but also hyperlipidemia, partly via inhibiting the induction of the key lipogenic enzyme ACC and the master lipogenic factor SREBP-1C. This evidence concerns the gene HNF4A and hyperlipidemia.